Lucid Diagnostics Inc
NASDAQ:LUCD
Cash Flow Statement
Cash Flow Statement
Lucid Diagnostics Inc
Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||
Net Income |
(22)
|
(28)
|
(40)
|
(45)
|
(53)
|
(56)
|
(60)
|
(57)
|
(57)
|
(53)
|
(47)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
2
|
3
|
2
|
2
|
2
|
2
|
|
Other Non-Cash Items |
6
|
10
|
14
|
14
|
15
|
16
|
18
|
15
|
15
|
12
|
7
|
|
Change in Working Capital |
4
|
1
|
3
|
(1)
|
1
|
9
|
9
|
15
|
12
|
6
|
(0)
|
|
Cash from Operating Activities |
(11)
N/A
|
(18)
-60%
|
(23)
-33%
|
(31)
-33%
|
(35)
-13%
|
(30)
+16%
|
(31)
-4%
|
(25)
+20%
|
(27)
-10%
|
(33)
-21%
|
(38)
-17%
|
|
Investing Cash Flow | ||||||||||||
Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Other Items |
0
|
0
|
0
|
(2)
|
(3)
|
(3)
|
0
|
(1)
|
0
|
0
|
0
|
|
Cash from Investing Activities |
(0)
N/A
|
(1)
-2 050%
|
(1)
-17%
|
(3)
-240%
|
(5)
-38%
|
(4)
+13%
|
(4)
+3%
|
(2)
+61%
|
(0)
+84%
|
(0)
+12%
|
(0)
-8%
|
|
Financing Cash Flow | ||||||||||||
Net Issuance of Common Stock |
0
|
70
|
70
|
71
|
73
|
3
|
17
|
16
|
14
|
19
|
24
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
10
|
10
|
0
|
|
Other |
10
|
2
|
2
|
(6)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
10
N/A
|
72
+592%
|
72
+0%
|
65
-10%
|
67
+3%
|
3
-96%
|
27
+916%
|
26
-2%
|
24
-6%
|
29
+20%
|
24
-19%
|
|
Change in Cash | ||||||||||||
Net Change in Cash |
(1)
N/A
|
54
N/A
|
48
-11%
|
30
-36%
|
27
-12%
|
(31)
N/A
|
(8)
+73%
|
(0)
+99%
|
(3)
-2 308%
|
(4)
-24%
|
(15)
-312%
|
|
Free Cash Flow | ||||||||||||
Free Cash Flow |
(11)
N/A
|
(19)
-68%
|
(24)
-32%
|
(32)
-32%
|
(37)
-14%
|
(31)
+17%
|
(32)
-4%
|
(25)
+21%
|
(27)
-8%
|
(33)
-21%
|
(39)
-17%
|